FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Karen McCarthy

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Disorders

Physiology

Anatomy

T-Lymphocytes

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Thomas P Monath; Jian Liu; Niranjan Kanesa-Thasan; Gwendolyn A Myers; Richard Nichols; Alison Deary; Karen McCarthy; Casey Johnson; Thomas H Ermak; Sunheang Shin; Juan Arroyo; Farshad Guirakhoo; Jeffrey S Kennedy; Irene Bosch; Sharone Green; Philip Bedford
A live, attenuated recombinant West Nile virus vaccine.
Farshad Guirakhoo; Scott Kitchener; Dennis Morrison; Remi Forrat; Karen McCarthy; Richard Nichols; Sutee Yoksan; Xiaochu Duan; Thomas H Ermak; Niranjan Kanesa-Thasan; Philip Bedford; Jean Lang; Marie-Jose Quentin-Millet; Thomas P Monath
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
Thomas P Monath; Martin S Cetron; Karen McCarthy; Richard Nichols; W Tad Archambault; Leisa Weld; Philip Bedford
Yellow fever 17D vaccine safety and immunogenicity in the elderly.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Karen McCarthy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Thomas P Monath; Jian Liu; Niranjan Kanesa-Thasan; Gwendolyn A Myers; Richard Nichols; Alison Deary; Karen McCarthy; Casey Johnson; Thomas H Ermak; Sunheang Shin; Juan Arroyo; Farshad Guirakhoo; Jeffrey S Kennedy; Irene Bosch; Sharone Green; Philip Bedford
A live, attenuated recombinant West Nile virus vaccine.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(17):6694-9.
2006: Farshad Guirakhoo; Scott Kitchener; Dennis Morrison; Remi Forrat; Karen McCarthy; Richard Nichols; Sutee Yoksan; Xiaochu Duan; Thomas H Ermak; Niranjan Kanesa-Thasan; Philip Bedford; Jean Lang; Marie-Jose Quentin-Millet; Thomas P Monath
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
Human vaccines 2006;2(2):60-7.
2005: Thomas P Monath; Martin S Cetron; Karen McCarthy; Richard Nichols; W Tad Archambault; Leisa Weld; Philip Bedford
Yellow fever 17D vaccine safety and immunogenicity in the elderly.
Human vaccines 2005;1(5):207-14.
2005: Vivian E Belmusto-Worn; Jose L Sanchez; Karen McCarthy; Richard Nichols; Christian T Bautista; Alan J Magill; Giovanna Pastor-Cauna; Carlos Echevarria; Victor A Laguna-Torres; Billey K Samame; Maria E Baldeon; James P Burans; James G Olson; Philip Bedford; Scott Kitchener; Thomas P Monath
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru.
The American journal of tropical medicine and hygiene 2005;72(2):189-97.
2005: Casey Johnson; Thomas P Monath; Niranjan Kanesa-Thasan; Danell Mathis; Chuck Miller; Seth Shapiro; Richard Nichols; Karen McCarthy; Alison Deary; Philip Bedford
Exercise-induced serum enzyme elevations confounding the evaluation of investigational drug toxicity. Report of two cases in a vaccine trial.
Human vaccines 2005;1(1):24-9.
2003: Thomas P Monath; Farshad Guirakhoo; Richard Nichols; Sutee Yoksan; Robert Schrader; Chris Murphy; Paul Blum; Stephen Woodward; Karen McCarthy; Danell Mathis; Casey Johnson; Philip Bedford
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
The Journal of infectious diseases 2003;188(8):1213-30.
2002: Thomas P Monath; Karen McCarthy; Philip Bedford; Casey T Johnson; Richard Nichols; Sutee Yoksan; Ron Marchesani; Michael Knauber; Keith H Wells; Juan Arroyo; Farshad Guirakhoo
Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections.
Vaccine 2002;20(7-8):1004-18.